Mohammed Ahmed Akkaif is currently a Ph.D. candidate in the Department of Clinical Pharmacy, School of Pharmaceutical Science, University Sains Malaysia. He participated in many international conferences and had several publications in peer-reviewed journals. He has a specific interest in antithrombotic pharmacotherapies. His research activity also involves the pharmacogenetic and pharmacometabolomic approach to personalized antiplatelet therapy.
Platelet reactivity index after treatment of clopidogrel versus ticagrelor based on CYP2C19 genotypes among patients undergoing percutaneous coronary intervention: results of a randomized study
Event: ESC Asia 2022 with APSC & AFC
Topic: Cardiovascular Pharmacotherapy
Session: Young Investigator Award Competition
ESC 365 is supported by
